HeartBeam announced today that it received FDA 510(k) clearance for its comprehensive arrhythmia assessment system.
HeartBeam (BEAT) announced that the US Food and Drug Administration FDA has granted 510(k) clearance of the HeartBeam system for comprehensive ...